New Enterprise Associates 17, L.P.

Insider Reports History

Entity: Company
Location: 1954 Greenspring Drive, Suite 600, Timonium, MD
Signature: /s/ Zachary Bambach, attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by New Enterprise Associates 17, L.P.:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Monte Rosa Therapeutics, Inc.	10%+ Owner	Common Stock	7.69M	$146M	$19.00	Jun 28, 2021	Direct
Korro Bio, Inc.	10%+ Owner	Common Stock	1.09M	$61.1M	$56.00	Apr 22, 2024	Direct
MBX Biosciences, Inc.	10%+ Owner	Common Stock	3.61M	$38.6M	$10.69	Sep 16, 2024	Direct
NeueHealth, Inc.	10%+ Owner	Warrant (Right to Buy)	186K			Oct 1, 2024	Direct
MBX Biosciences, Inc.	10%+ Owner	Series A Convertible Preferred Stock	0			Sep 16, 2024	Direct
MBX Biosciences, Inc.	10%+ Owner	Series B Convertible Preferred Stock	0			Sep 16, 2024	Direct
Monte Rosa Therapeutics, Inc.	10%+ Owner	Series A-2 convertible preferred stock	0			Jun 28, 2021	Direct
Monte Rosa Therapeutics, Inc.	10%+ Owner	Series B convertible preferred stock	0		$2.00	Jun 28, 2021	Direct
Monte Rosa Therapeutics, Inc.	10%+ Owner	Series C convertible preferred Stock	0		$2.96	Jun 28, 2021	Direct

Showing 1 to 9 of 9 entries

Insider Reports Filed by New Enterprise Associates 17, L.P.

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
NEUE	NeueHealth, Inc.	Oct 1, 2024	1	$0	4	Oct 3, 2024	10%+ Owner
MBX	MBX Biosciences, Inc.	Sep 16, 2024	5	$8M	4	Sep 17, 2024	10%+ Owner
MBX	MBX Biosciences, Inc.	Sep 12, 2024	0	$0	3	Sep 12, 2024	10%+ Owner
KRRO	Korro Bio, Inc.	Apr 22, 2024	1	$1M	4	Apr 24, 2024	10%+ Owner
NEUE	NeueHealth, Inc.	Apr 8, 2024	1	$0	4	Apr 10, 2024	10%+ Owner
FREQ	Korro Bio, Inc.	Nov 3, 2023	0	$0	3	Nov 7, 2023	10%+ Owner
BHG	Bright Health Group Inc.	Oct 17, 2022	0	$0	3/A	Oct 20, 2022	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Jun 28, 2021	7	$20M	4	Jun 30, 2021	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Jun 23, 2021	0	$0	3	Jun 23, 2021	10%+ Owner